Dr. Paul Auerbach is the world's leading outdoor health expert. His blog offers tips on outdoor safety and advice on how to handle wilderness emergencies.See all posts »
The Global Snakebite Crisis
By their reasoning, the authors present the case that perhaps the current approach to antivenom issues is not adequate, and compounded by a lack of implementation of key solutions, such as training doctors in developing countries with relevant protocols.
Multiple flaws in snake antivenom (ASV) production and distribution are revealed, including selection of venoms against which to create ASVs, unscrupulous behavior by certain manufacturers, assumptions about the epidemiology of snakebites, definition of envenomation syndromes, estimations of mortality, sustainability of the current economic model, and others. The authors do not merely sit back and take shots at what they perceive to be flaws. They offer a practical model for how it might be possible to achieve solutions for most of these issues.
This paper has already stimulated a great deal of discussion, and will undoubtedly be viewed by some readers as provocative. The topic of snake bite, and therefore ASV production, distribution, and use, is on the agenda of the World Health Organization. Anyone interested in venomous snakebite and the medical-economic-social-political issues related to antivenom and other medical interventions for envenomation, would be interested in reading this paper carefully, and considering how best to determine if there is a need to validate the contentions and suggestions.
image courtesy of www.itsnature.org
Preview the Annual Meeting of the Wilderness Medical Society, which will be held in Snowmass, Colorado July 24-29, 2009.
Tags: snakebite, antivenom, snake bite, wilderness medicine, outdoor medicine, healthline
Recent Blog Posts
Jul 01, 2013
In Advance of a Wildfire
Feb 11, 2013
Topical Ivermectin Lotion for Treating Head Lice
Feb 04, 2013
Public Health Interventions and Snowmobile Fatality Rates